Comparative Evaluation of Pulpotomized Primary Molars With Mineral Trioxide Aggregate and New Endodonthic Cement
NCT ID: NCT00802256
Last Updated: 2009-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
80 participants
INTERVENTIONAL
2008-10-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Comparison of Indirect Pulp Therapy and Mineral Trioxide Aggregate Pulpotomy in Decayed Primary Molars
NCT02620826
Comparison of The Success Rates of Four Different Pulpotomy Techniques
NCT03135626
Single Rotary File System Versus Conventional Manual K-file in Pulpectomy of Primary Molars.
NCT06151665
Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate and Biodentine as Pulp Medicaments in Primary Molars
NCT05102318
Clinical and Radiographic Success of Pulpotomy Using Neoputty Mineral Trioxide Aggregate Versus Pulpectomy Using Endoflas In Primary Molars With Irreversible Pulpitis: A Randomized Controlled Trial
NCT06922578
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
teeth which are treated with Mineral Trioxide Aggregate (MTA) material
pulpotomy
removal of caries and cronal pulp tissue and then restoring of tooth
B
teeth which are treated with new Endodontic Cement (NEC) material
pulpotomy
removal of caries and cronal pulp tissue and then restoring of tooth
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pulpotomy
removal of caries and cronal pulp tissue and then restoring of tooth
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No clinical signs \& symptoms like pain,inflammation
* No radiographic signs \& symptoms like: internal resorption,external resorption, furcation involvement,pulp canal obliteration.
* The restorable tooth
* No dental treatment contraindication
Exclusion Criteria
* Existence of pain,inflammation or sinus tract
* No patient compliance
4 Years
8 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Iranian center for endodontic research
UNKNOWN
Shahid Beheshti University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shaheed Beheshti University of Medical Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fatemeh Shekarchi, student
Role: PRINCIPAL_INVESTIGATOR
Saheed Behesti University for Medical sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saheed Behesti University for Medical sciences
Tehran, , Iran
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
63sh138
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.